Kidney cancer

Last updated: 01 November 2019

You can legally access new medicines, even if they are not approved in your country.

Learn more »

A new study found that cabozantinib (Cabometyx) was more effective than everolimus in advanced renal cell carcinoma and bone metastases.

Read more